ArticleFrontiers in oncology2026
Whole-volume apparent diffusion coefficient histogram analysis for prediction of programmed cell death ligand 1 expression in periampullary carcinomas: a preliminary study.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess the possibility of employing whole-volume ADC histogram analysis for predicting programmed cell death ligand 1 (PD-L1) expression in periampullary carcinomas (PCs). Materials and methods: We retrospectively evaluated imaging records of 65 patients with PC who received pancreaticoduodenectomy in our hospital. PD-L1 expression was systematically categorized as positive or negative based on the tumor proportion score (TPS), immune cell score (ICS), and the combined positive score (CPS), with an immunohistochemistry assay. Univariate analysis was conducted to assess differences in parameters between PD-L1-positive and PD-L1-negative groups. Spearman's correlation analysis was utilized to explore associations between variables and PD-L1 expression. Receiver operating characteristic (ROC) analysis was performed to evaluate the differential diagnostic performance of parameters in distinguishing two groups. Results: Several ADC histogram parameters were significantly different between PD-L1-positive and PD-L1-negative group, and showed significant correlations with PD-L1 expression, most notably the 5th and 10th percentiles. In TPS grouping, the 5th percentile demonstrated the highest area under the curve (AUC) of 0.690, which was improved to 0.740 when combined with tumor size and carbohydrate antigen 19-9. In ICS grouping, the 10th percentile showed the highest AUC of 0.690, which was improved to 0.772 when integrated with the degree of differentiation. In CPS grouping, the 5th percentile demonstrated the highest AUC of 0.694, which was improved to 0.752 when combined with tumor size and carcinoembryonic antigen. Conclusion: Whole-volume ADC histogram parameters of primary tumors hold great potential in predicting PD-L1 expression in PCs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.